How long does it take for lion's mane to work for memory?

The one memory trial read as the graph it is: six assessment points, where the lines sit at each, and what the graph says about how long in the population it was drawn in

How long does it take for lion's mane to work for memory is a question with exactly one source, and the source is best read as the graph its authors published rather than as the headline the trade quotes, because the graph answers the question point by point. The trial enrolled thirty Japanese adults aged 50 to 80 with a diagnosis of mild cognitive impairment, randomised them to 3g a day of lion's mane fruiting body powder in tablets or to matching placebo, and assessed every participant on a cognitive scale at six points: baseline, and weeks four, eight, twelve and sixteen on the tablets, then week twenty after four weeks without them. Plotted, the two lines start together at baseline, as randomisation intends. At week four they are still together: the lion's mane group has not separated from placebo, which is the first thing the graph says about how long, that one month is not enough to show anything on this scale in this population. At week eight the lines part, with the lion's mane group scoring higher by a margin that reached statistical significance, which is the trial's answer to when it starts working: eight weeks. At weeks twelve and sixteen the gap widens, each assessment finding the lion's mane group further above placebo than the last, so that sixteen weeks, the trial's end, is where the effect was largest, with no data on whether it would have kept widening, plateaued or faded had the trial run on. At week twenty, four weeks after the tablets stopped, the lion's mane line has fallen back toward placebo, the gap closing substantially, which is the graph's final statement: whatever was happening depended on continued intake and left within a month of stopping.

Read as a graph, then, the trial gives three durations and a condition. Eight weeks to the first measurable separation. Sixteen weeks to the widest, which is also the longest anyone has been studied. Four weeks to lose it. And the condition, which is the part the trade drops: in that population, on that scale. The population was older adults with diagnosed impairment, people whose memory was measurably below normal for their age when the trial began, and the scale was an instrument designed to detect and grade exactly that impairment, scoring attention, orientation, recall and related functions and producing a total that falls as cognition declines. Both facts matter for anyone outside the population, and the second matters more than most readers realise, because it is not merely a question of whether the effect generalises but of whether the effect could be seen at all in a person who was not impaired to begin with. The trial also recorded no serious adverse events and no liver or kidney signal across the sixteen weeks, so its safety clock runs to the same point its efficacy clock does, and a buyer who treats the tub as a sixteen-week course is at least inside the duration anyone has been watched taking it. One more thing the graph does not show deserves saying: the trial has never been replicated at scale, in any population, and a single trial of thirty people is the whole of the memory evidence on which every memory tub is sold.

The ceiling effect: why a scale built to detect impairment may have nowhere to move in a healthy lifter, what that does to the question, the instrument a lifter should use instead, and the honest buy

The ceiling effect is the fact that decides whether the trial's graph can be drawn for a healthy thirty-year-old, and it is worth understanding properly because it is the most common reason cognitive supplements show nothing in healthy people. A scale developed to detect impairment is built so that impaired people score low and lose points as they decline; it is not built to separate good from very good, and healthy adults taking it cluster at or near the maximum score before any intervention, with most of them making no errors at all. A scale a person has already topped cannot register improvement, however real an underlying effect might be, because there is no room above the maximum for the score to move into, and a trial of such a scale in healthy adults would show nothing for the mushroom and nothing for anything else, not because the interventions failed but because the ruler ran out. This is a well-documented property of the screening instruments used in impairment trials, and it means that the question of how long lion's mane takes to work for memory in a healthy lifter is not just unanswered by the trial but possibly unanswerable on the trial's own instrument: a lifter who took the trial's scale at baseline, eight and sixteen weeks would most likely score at the top on all three and learn nothing, whether or not anything was happening. The ceiling effect does not say the mushroom does nothing in healthy adults; it says that the only evidence for the mushroom comes from a population and a scale in which there was room to move, and that the absence of evidence in healthy adults is partly a measurement problem that no amount of hoping fills.

What a lifter should take from this is a method rather than a verdict. The trial's clock, eight weeks to separation and sixteen to the widest, is the only clock there is, so a person who runs the mushroom runs it for sixteen weeks, which a 120-capsule tub covers, and reads nothing into the first month because the trial read nothing into it either. But the instrument has to have headroom, which means not a screening scale and not a feeling, since feelings top out faster than scales and are moved by expectancy at several per cent in blinded studies. A word-list recall task, in which a person studies a list of fifteen unrelated words and writes down as many as they can after a short delay, has headroom in healthy adults, since almost nobody recalls all fifteen; a digit-span task, repeating increasing strings of numbers forward and backward, has headroom for the same reason; free apps and paper versions of both exist, and the method is to run the same task at baseline, at eight weeks and at sixteen, under the same conditions, at the same time of day, and after the same night's sleep as far as possible, and then once more after a fortnight off, since the trial's washout says any real effect should fade and a score that does not fall on stopping was never the mushroom's. A person who sees a repeatable rise at eight and sixteen that falls on stopping has a result worth having; a person who sees the ordinary practice effect, in which any repeated test improves for a few sessions, has learned about practice, which is why a baseline run of two or three attempts before starting matters. The memory systems themselves, working, episodic, semantic, procedural and prospective, are built by sleep, by use and by the inputs that no capsule supplies, and the honest expectation for a healthy lifter is a test that does not move; a lifter who wants to run the experiment properly can do so for 13p a day on the worked example, {FLLM}, a stated 5:1 fruiting body extract labelled 1500mg mushroom equivalent per capsule, 120 days for £15.49, UK made, independently lab tested, with a tub the length of the trial's clock and nothing about memory on the label, because the word belongs to no supplement.

What to check on the label

Questions people also ask

When does lion's mane start working for memory?

At week eight, in the only trial: thirty older adults with mild cognitive impairment taking 3g a day of fruiting body powder were no different from placebo at week four on a cognitive scale, separated at week eight, and widened the gap at twelve and sixteen, with the effect fading in a four-week washout; a person judging the mushroom after a month has judged a period the trial itself found empty, and nothing has been measured in healthy adults.

Does lion's mane improve memory in healthy people?

No trial has shown it, and part of the reason is measurement: the scale used in the impairment trial clusters healthy adults at or near its maximum before any intervention, so it cannot register improvement in a normal scorer however real an effect might be, which is the ceiling effect; a healthy young adult pilot measured a Stroop test rather than memory and found an unfelt signal at 60 minutes and nothing at four weeks; the honest statement is unmeasured, with a method for measuring it yourself.

How can I test whether lion's mane helps my memory?

Use an instrument with headroom and repeat it: a fifteen-word list recalled after a short delay, or a digit-span task forward and backward, run two or three times before starting to absorb the practice effect, then at eight weeks and sixteen weeks under matched conditions, same time of day and a similar night's sleep, and once more after a fortnight off; a repeatable rise that falls on stopping is a result, a rise that stays was practice or something else, and a feeling is not an instrument.

How long should I take lion's mane for memory?

Sixteen weeks is the longest anyone has been studied taking it and the point at which the trial's effect was widest, so a 120-capsule tub at one a day covers the clock; the trial's washout showed the effect leaving within four weeks of stopping, which makes a fortnight off at the end of the tub both a safety pause and the test of whether anything was happening, and nothing has been studied beyond sixteen weeks in any population.

Why did lion's mane work in the trial but not in other studies?

The trial's participants had measurable impairment and room on the scale to improve, while the young-adult pilot's participants were healthy and tested on a different task with a different clock; a single trial of thirty people has never been replicated at scale in any population, so the memory finding stands as one small positive result in impaired older adults, and the ceiling effect means that a null result in healthy adults on an impairment scale would tell nobody anything either way.

Sources

1. Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research 2009;23(3):367-372. PubMed record
2. The ceiling effect literature in cognitive outcome measures: scales developed to detect impairment, including the screening instruments used in mild cognitive impairment trials, cluster healthy adults at or near the maximum score, so that an intervention cannot show improvement in a cognitively normal person on such a scale regardless of any real effect. PubMed record
3. The cognitive assessment literature: validated instruments such as the Montreal Cognitive Assessment, digit span, trail making and the Stroop task are standardised, normed and administered under controlled conditions, which online brain fog quizzes are not. PubMed record
4. The memory systems literature: working, episodic, semantic, procedural and prospective memory are distinct systems with different neural bases and different tests, so a single cognitive screening scale measures some and not others, and an intervention's effect on one system does not imply an effect on another. PubMed record

Related answers

• How long does lion's mane take to work for anxiety?
• How much lion's mane dosage should you take for memory?
• Does lion's mane help with memory?
• How quickly does Lion Mane work?
• What are the best lion's mane supplement for memory in the UK?
• How to know if lion's mane is good quality?